Skip to main content

Peer Review reports

From: Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

Original Submission
22 May 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
22 Jul 2012 Reviewed Reviewer Report - Philippe Beutels
9 Aug 2012 Reviewed Reviewer Report - Walter G W Ricciardi
14 Aug 2012 Reviewed Reviewer Report - Eduardo Lazcano-Ponce
19 Oct 2012 Author responded Author comments - Tjalke Westra
Resubmission - Version 5
19 Oct 2012 Submitted Manuscript version 5
18 Nov 2012 Reviewed Reviewer Report - Walter G W Ricciardi
17 Dec 2012 Author responded Author comments - Tjalke Westra
Resubmission - Version 6
17 Dec 2012 Submitted Manuscript version 6
Publishing
25 Jan 2013 Editorially accepted
7 Feb 2013 Article published 10.1186/1471-2334-13-75

You can find further information about peer review here.

Back to article page